Solid Power, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Solid Power, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.75M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $20.14M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $17.41M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $11.79M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $2.71M | Mar 1, 2023 |
| FY2022 | Dec 31, 2020 | $2.10M | Mar 1, 2023 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.91M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $20.14M | Feb 25, 2026 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($93.41M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($96.52M) | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | ($65.55M) | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | ($9.56M) | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $18.09M | Mar 1, 2023 |
| FY2022 | Dec 31, 2020 | ($14.38M) | Mar 1, 2023 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($100.83M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($105.33M) | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | ($90.62M) | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | ($59.12M) | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | ($26.55M) | Mar 1, 2023 |
| FY2022 | Dec 31, 2020 | ($11.59M) | Mar 1, 2023 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $72.51M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $73.34M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $54.75M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $38.59M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $17.10M | Mar 1, 2023 |
| FY2022 | Dec 31, 2020 | $9.59M | Mar 1, 2023 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $29.42M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $31.85M | Feb 25, 2026 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($73.39M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($63.90M) | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | ($58.26M) | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | ($33.82M) | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | ($25.44M) | Mar 1, 2023 |
| FY2022 | Dec 31, 2020 | ($10.00M) | Mar 1, 2023 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.21M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $15.94M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $34.51M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $58.30M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $12.62M | Mar 1, 2023 |
| FY2022 | Dec 31, 2020 | $1.02M | Mar 1, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $455.09M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $448.25M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $532.79M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $594.45M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $617.68M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $14.21M | Mar 23, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $38.92M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $37.94M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $29.46M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $39.07M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $59.02M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $10.34M | Mar 23, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $415.70M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $410.28M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $503.34M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $555.37M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $558.67M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $3.87M | Mar 1, 2023 |
| FY2022 | Dec 31, 2019 | ($16.20M) | Mar 1, 2023 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $0 | Mar 1, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($274.90M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($181.17M) | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | ($84.64M) | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | ($19.09M) | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | ($9.54M) | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | ($27.63M) | Mar 23, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.61M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $25.41M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $34.54M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $50.12M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $513.45M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $4.97M | Mar 23, 2022 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $7.0K | Mar 1, 2023 |
| FY2022 | Dec 31, 2021 | $130.0K | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $2.72M | Mar 23, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 1, 2023 |
| FY2022 | Dec 31, 2020 | 0 | Mar 1, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 1, 2023 |
| FY2022 | Dec 31, 2020 | 0 | Mar 1, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 201.18M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 180.36M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | 179.01M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | 176.01M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | 167.56M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | 69.89M | Mar 23, 2022 |